ArticleThe Journal of antimicrobial chemotherapy2025

In vitro and clinical data demonstrate negligible risk of drug-drug interactions with opelconazole, a novel inhaled antifungal agent.

Lindsey M R Cass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.